Medicamen Biotech Ltd Q4 FY2025-2026 Results: Summary
Revenue | ₹62.38Cr |
Net Profits | ₹3.86Cr |
Net Profit Margins | 6.19% |
Medicamen Biotech Ltd’s revenue jumped 79.05% since last year same period to ₹62.38Cr in the Q4 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 31.49% jump in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit jumped 59.5% since last year same period to ₹3.86Cr in the Q4 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 76.26% jump in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin fell -10.91% since last year same period to 6.19% in the Q4 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated 34.04% jumped in its net profit margins since last 3-months.
FAQs
What was the revenue for Medicamen Biotech Ltd in Q4 results 2025?
The revenue for Medicamen Biotech Ltd in the Q4 results 2025 was ₹62.38Cr.
What was the net profit for Medicamen Biotech Ltd in Q4 results 2025?
The net profit for Medicamen Biotech Ltd in the Q4 results 2025 was ₹3.86Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q4 results 2025?
The net profit margin for Medicamen Biotech Ltd in the Q4 results 2025 was 6.19%.
What was the revenue for Medicamen Biotech Ltd in Q4 results 2024?
The revenue for Medicamen Biotech Ltd in the Q4 results 2024 was ₹34.84Cr.
What was the net profit for Medicamen Biotech Ltd in Q4 results 2024?
The net profit for Medicamen Biotech Ltd in the Q4 results 2024 was ₹2.42Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q4 results 2024?
The net profit margin for Medicamen Biotech Ltd in the Q4 results 2024 was 6.95%.
